POPULARITY
In this episode, we go behind the scenes where Scott Ely talks to Antonio Rozich — his creative collaborator and co-writer on most of the episodes — on how they met, what it takes to be a creative writer and other odd background stories from creating Season One of Evolve Faster Podcast. From joint eureka moments to pointless yet heated arguments over if a character should go left or right on a river fork, this interview dissects how creativity can sometimes be better as both a shared and an individual process.
Welcome to the first Ask me Anything (AMA) Episode, which will be loosely framed around the question ... Who controls your narrative? Evolve Faster is my laboratory to write and think about ideas in an attempt to learn to be a better human…which can be surprisingly difficult. But with a series of minor mindset shifts, it doesn’t have to be so hard.
Scott Ely, Curriculum Director at Spring Lake Public Schools, shares how he provides choice, flexibility and unique collaboration opportunities for his teachers through online professional development. Connect with Scott via email at sely@springlakeschools.org Our team of instructional coaches is available to help ANY teacher, ANYwhere. Learn more or just peruse our other resources (blogs, classes, monthly newsletter) and services (events, virtual support, quick chats or calls) at cbdconsulting.com/elevateEDU
We know that exercise is the key to a long and healthy life but a lot of our kids are not getting the exercise they need. Loraine Ballard Morrill talks with Scott Ely - VP Operations and Tamara Conan, Director of Healthy Kids Running Series about their five week program for kids from pre-k to 8th grade. http://www.healthykidsrunningseries.org.
On today's show we play MindGames. Lil Stephen hosts and the real Scott Ely and The Summitt battle at wrestling trivia. You can listen to us on these platforms.iTunesStitcherSpreakerWe also stream our show live during recording on Periscope.If you enjoy the show, like us on Facebook athttps://www.facebook.com/Wrestlingwithattitude/
On today's show we play MindGames. Lil Stephen hosts and the real Scott Ely and The Summitt battle at wrestling trivia. You can listen to us on these platforms. iTunes Stitcher Spreaker We also stream our show live during recording on Periscope. If you enjoy the show, like us on Facebook athttps://www.facebook.com/Wrestlingwithattitude/
On today's show we rank the top 5 jobbers of all time in wrestling in our segment called WWA SoundOff where your voice can be heard. We also talk with the real Scott Ely on why Smackdown and Raw struggle at making talent.You can listen to us on these platforms.iTunesStitcherSpreakerWe also stream our show live during recording on Periscope.If you enjoy the show, like us on Facebook athttps://www.facebook.com/Wrestlingwithattitude/
On today's show we rank the top 5 jobbers of all time in wrestling in our segment called WWA SoundOff where your voice can be heard. We also talk with the real Scott Ely on why Smackdown and Raw struggle at making talent. You can listen to us on these platforms. iTunes Stitcher Spreaker We also stream our show live during recording on Periscope. If you enjoy the show, like us on Facebook athttps://www.facebook.com/Wrestlingwithattitude/
Dr Ely talks to ecancertv at the 14th International Myleoma Workshop, Kyoto, Japan, 3-7th April 2013. There are now several treatment options for myeloma but little data to help decide which drugs to use. A proliferation assay devised in the 1980s showed proof of principle, that assessment of proliferation is an accurate predictor of clinical behavior. Since then, for technical reasons, clinical implementation of a proliferation assay has not been successful. The researchers invented an immunohistochemical platform (U.S. patents applied) to assess myeloma proliferation. Unlike prior methods, it is performed at the single-cell level, on routinely-preserved marrow, using standard laboratory equipment. The test can be read manually or via image analysis, using the software (U.S. copyright applied) which runs on any PC or Mac. The prospective analysis of patients followed 14 years after an IRB-approved BMT trial showed an inverse correlation between survival and myeloma cell proliferation (P = 0.006). Also, the retrospective cohort study showed that each 1% increase in proliferation was associated with a 3% increase in risk of progression (P = 0.02). PFS was 232 weeks vs. 110 weeks for 10%, respectively (P = 0.03). The new assay provides reliable prognostic information that can be used to approach care on a patient-specific basis. Because the assay can be performed currently in any diagnostic laboratory, the researchers believe patients would benefit from its standard use in clinical trials. It would improve upon current practice by providing biologic tumthe behavior data. Such data might predict well, which drugs would work best in an individual patient.